Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Tel Aviv - Delayed Quote ILA

Tikun Olam-Cannbit Pharmaceuticals Ltd (TKUN.TA)

Compare
38.00
-2.00
(-5.00%)
At close: 2:11:11 PM GMT+2
Currency in ILS All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
44,228
44,228
49,297
37,030
21,658
Cost of Revenue
45,985
45,985
46,864
44,372
17,768
Gross Profit
-1,757
-1,757
2,433
-7,342
3,890
Operating Expense
26,715
26,715
29,104
34,850
35,871
Operating Income
-28,472
-28,472
-26,671
-42,192
-31,981
Net Non Operating Interest Income Expense
-2,301
-2,301
-1,681
-1,269
-1,139
Pretax Income
-93,991
-93,991
-49,137
-34,027
-35,023
Tax Provision
25
25
12
--
-273
Net Income Common Stockholders
-88,886
-88,886
-48,235
-32,651
-32,941
Diluted NI Available to Com Stockholders
-88,886
-88,886
-48,235
-32,651
-32,941
Basic EPS
-1.41
-1.41
-0.95
-0.78
-0.90
Diluted EPS
-1.41
-1.41
-0.95
-0.78
-0.90
Basic Average Shares
63,016.79
63,016.79
50,794.02
42,012.90
36,415.58
Diluted Average Shares
63,016.79
63,016.79
50,794.02
42,012.90
36,415.58
Total Operating Income as Reported
-91,391
-91,391
-49,388
-32,758
-33,883
Total Expenses
72,700
72,700
75,968
79,222
53,639
Net Income from Continuing & Discontinued Operation
-88,886
-88,886
-48,235
-32,651
-32,941
Normalized Income
17,077.06
17,077.06
8,380.76
-32,504
-31,477.50
Interest Income
--
--
--
11
51
Interest Expense
2,301
2,301
1,767
1,280
1,190
Net Interest Income
-2,301
-2,301
-1,681
-1,269
-1,139
EBIT
-91,690
-91,690
-47,370
-32,747
-33,833
EBITDA
-32,980
-32,980
4,831
-13,044
-19,897
Reconciled Cost of Revenue
45,985
45,985
46,864
44,372
17,768
Reconciled Depreciation
58,710
58,710
52,201
19,703
13,936
Net Income from Continuing Operation Net Minority Interest
-88,886
-88,886
-48,235
-32,651
-32,941
Total Unusual Items Excluding Goodwill
-60,178
-60,178
-30,888
-147
-1,475
Total Unusual Items
-552
-552
1,944
-147
-1,475
Normalized EBITDA
-32,428
-32,428
2,887
-12,897
-18,422
Tax Rate for Calcs
0
0
0
--
0
Tax Effect of Unusual Items
-13,840.94
-13,840.94
-7,104.24
--
-11.50
12/31/2020 - 8/12/2002

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

EVT.VI Evotec SE
8.50
-0.82%
 
PLCN.CN Cannibble Food-Tech Ltd.
0.0200
-33.33%
 
N4P.L N4 Pharma Plc
0.5750
0.00%
 
BOI.PA Boiron SA
25.20
+1.00%
 
TEV.F Teva Pharmaceutical Industries Limited
16.10
-2.13%
 
RJF.MC Laboratorio Reig Jofre, S.A.
2.6900
+1.13%
 
3320.HK China Resources Pharmaceutical Group Limited
5.480
+1.29%
 
DICOT.ST Dicot Pharma AB
0.2655
+1.53%
 
CLCFF Christina Lake Cannabis Corp.
0.0400
0.00%
 
BIOG-B.ST BioGaia AB (publ)
127.00
-0.31%